<DOC>
	<DOCNO>NCT02865616</DOCNO>
	<brief_summary>To measure resolution diarrhea well feasibility administration safety MET-1 treatment recurrent CDI patient experience least two prior episode CDI develop recurrence complete standard-of care oral antibiotic therapy treat CDI .</brief_summary>
	<brief_title>MET-1 Clinical Pilot Study Recurrent C. Difficile</brief_title>
	<detailed_description>The primary endpoint clinical resolution diarrhea CDI relapse 30 day follow last dose MET-1 , i.e. , absence recurrence diarrheal symptom ( see definition section ) laboratory-confirmed evidence C. difficile 30 day . The secondary endpoint : ) safety tolerability , include adverse event grade 2 ; ii ) overall well-being include number bowel movement energy level , etc base standardize IBS questionnaire ( see appendix ) ; iii ) presence MET-1 bacteria stool 30 day , base DNA sequence ; iv ) mortality , end followup period - mortality attributable CDI also determine , perform detailed clinical chart review patient expire followup period . Open label , single center pilot study 20 patient . Patients meet inclusion criterion give four dos administer within 12 day ± 5 day ; first two dos give colonoscopy , third fourth dose via enema patient continue symptom post treatment . Patients vancomycin control symptoms time treatment . Patient must hold po vancomycin 24-48 hour prior receive first dose . Patients follow 6 month post-treatment .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>1 . ≥ 18 year old . 2 . Able provide inform consent , caregiver able provide consent 3 . Meets definition recurrent CDI ( see ) AND 4 . Has positive stool test C. difficile within 60 day enrolment 5 . Able undergo colonoscopy enemas 6 . Not pregnant 7 . Willing participate follow part study In addition , patient must agree undergo stool test 1 . Life expectancy &lt; 6 month 2 . Evidence severe CDI ( ( neutropenia ( ANC &lt; 1000 ) WBC &gt; 30 , creatinine &gt; 2X baseline , presence toxic megacolon intestinal perforation , admission ICU ) 3 . History chronic diarrhea 4 . Need regular use agent affect GI motility ( narcotic codeine morphine , agent loperamide metoclopramide ) 5 . Use antibiotic another infection ( CDI ) 6 . Colostomy 7 . Elective surgery require preop antibiotic plan within 6 month enrolment 8 . Pregnant plan get pregnant next 6 month 9. unable tolerate MET1 reason 10 . Any condition colonoscopy enema may contraindicate ( e.g. , neutropenia , thrombocytopenia , bleed disorder , severe colitis , etc ) 11 . Any condition , opinion investigator , patient exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>CDI</keyword>
	<keyword>recurrent infection</keyword>
	<keyword>MET-1</keyword>
	<keyword>C. difficile</keyword>
</DOC>